PureTech Health (OTCMKTS:PTCHF – Get Free Report) is expected to release its resultson Thursday, August 27th. Analysts expect PureTech Health to announce earnings of ($0.1160) per share and revenue of $24.80 million for the quarter.
PureTech Health Stock Performance
Shares of PureTech Health stock opened at $1.56 on Wednesday. The firm’s 50 day simple moving average is $1.60 and its two-hundred day simple moving average is $1.66. PureTech Health has a 12-month low of $1.53 and a 12-month high of $1.92.
PureTech Health Company Profile
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Read More
- Five stocks we like better than PureTech Health
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
